Terra Rossa Capital
Venture Capital
- Type
- Venture Capital
Strategies
Venture Capital
Breadth not publicly established
Investment Focus
Focus Areas
Stages
Series A Series B series c plus
Domains
Technology
Investment Geographies
Primary Markets
Australia New Zealand
Coverage
Country-focused Regions
Oceania
Coverage is a guide only.
People also viewed
Bailey Capital Management
Secured Venture Capital
Accel-KKR
Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.
Grok Ventures
Grok Ventures is the private investing vehicle of Mike Cannon-Brookes, co-founder of Atlassian and one of Australia's most successful technology entrepreneurs. Grok Ventures invests in fast-growing technology-enabled businesses with world-class management teams who are solving big problems. Grok particularly likes food and energy companies. We have private, patient, long-term capital, with the flexibility to participate from early-stage or seed financing through to late stage funding rounds (although we prefer to be involved earlier).
OneVentures
OneVentures is an Australian investment manager supporting technology and healthcare companies. Its investment pillars are Growth Equity, Growth Credit and Healthcare. Growth Equity backs Series A+ technology businesses scaling from product-market fit to global markets. Growth Credit provides debt financing for technology companies, while Healthcare invests in clinical-stage life sciences businesses developing therapeutics, medical devices and diagnostics.
Reinventure Group
Reinventure exists at the third horizon of growth, focused on creating options in future businesses through venture investment and a strategic relationship with our largest limited partner, Westpac Banking Corporation. With $100m to invest in FinTech and adjacent areas, we are uncovering, investing in and nurturing scalable early businesses that will be the future of the industry.